Research Article

Aldose Reductase Evaluation against Diabetic Complications Using ADME and Molecular Docking Studies and DFT Calculations of Spiroindoline Derivative Molecule

Volume: 28 Number: 2 August 23, 2024
TR EN

Aldose Reductase Evaluation against Diabetic Complications Using ADME and Molecular Docking Studies and DFT Calculations of Spiroindoline Derivative Molecule

Abstract

In this study, the target molecule ethyl-2-(5-nitro-5'-(4-nitrophenyl)-2-oxo-3'H-spiro[indoline-3,2'-[1,3,4]oxadiazol]-1-yl)acetate, which is a spiroindoline derivative, were performed NBO analysis, molecular electrostatic potential surface (MEPS), nonlinear optics (NLO), HOMO-LUMO energy calculations, optimized molecular geometry, and mulliken atomic charges using B3LYP/B3PW91 basis set and 6-311G(d,p) approximations. Calculated results were reported. Density Functional Theory (DFT) computations were utilized to research the molecule theoretically. Moreover, molecular docking analysis of the tested compound, a spiroindoline derivative molecule targeting aldose reductase against diabetic complications, was performed using molecular docking to determine the structure-activity connection. The molecular docking study provided important information worth considering for further research. A notable outcome of bioisosteric and isosteric substitutions is the alteration in lipophilic character, an impressive characteristic in several aspects. Thus, utilizing SwissADME, lipophilic character assessments were performed for the concerned compounds.

Keywords

References

  1. [1] Thakur, S., Gupta, S. K., Ali, V., Singh, P., Verma, M. 2021. Aldose Reductase: A cause and a potential target for the treatment of diabetic complications. Archives of Pharmacal Research, 44, 655-667.
  2. [2] Balestri, F., Moschini, R., Mura, U., Cappiello, M., Del, Corso. A. 2022. In search of differential inhibitors of aldose reductase. Biomolecules, 12(4), 485.
  3. [3] Papezikova, I., Pekarová, M., Chatzopoulou, M., Nicolaou, I., Demopoulos, V., Kubala, L., Lojek, A. 2008. The effect of aldose reductase inhibition by JMC-2004 on hyperglycemia-inducedendothelial dysfunction. Neuroendocrinology Letters, 29(5), 775.
  4. [4] Kumar, P. A., Reddy, G. B. 2007. Focus on molecules: aldose reductase. Experimental eye research, 85(6), 739-740.
  5. [5] Marchese, A. D., Larin, E. M., Mirabi, B., Lautens, M. 2020. Metal-catalyzed approaches toward the oxindole core. Accounts of Chemical Research, 53(8), 1605-1619.
  6. [6] Zhou, F., Liu, Y. L., Zhou, J. 2010. Catalytic asymmetric synthesis of oxindoles bearing a tetrasubstituted stereocenter at the C‐3 position. Advanced Synthesis & Catalysis, 352(9), 1381-1407.
  7. [7] Pavlovska, T. L., Redkin, R. G., Lipson, V. V., Atamanuk, D. V. 2016. Molecular diversity of spirooxindoles, Synthesis and biological activity. Molecular diversity, 20, 299-344.
  8. [8] Christy, N. A., Franks, A. S., Cross, L. B. 2005. Spironolactone for hirsutism in polycystic ovary syndrome. Annals of Pharmacotherapy, 39(9), 1517-1521. [9] Kolancilar, H. 2019. DFT Yöntemi Kullanılarak 1, 3-Bis-{(2-Aminobenzoil) Amino} Propanın Teorik Hesaplamaları ve Bu Değerlerin Literatürdeki Deneysel Değerler ile Karşılaştırılması. Düzce Üniversitesi Bilim ve Teknoloji Dergisi, 7(3), 1319-1334.

Details

Primary Language

English

Subjects

Analytical Chemistry (Other)

Journal Section

Research Article

Publication Date

August 23, 2024

Submission Date

April 27, 2024

Acceptance Date

August 13, 2024

Published in Issue

Year 2024 Volume: 28 Number: 2

APA
Gören, K., & Yıldıko, Ü. (2024). Aldose Reductase Evaluation against Diabetic Complications Using ADME and Molecular Docking Studies and DFT Calculations of Spiroindoline Derivative Molecule. Süleyman Demirel Üniversitesi Fen Bilimleri Enstitüsü Dergisi, 28(2), 281-292. https://doi.org/10.19113/sdufenbed.1474689
AMA
1.Gören K, Yıldıko Ü. Aldose Reductase Evaluation against Diabetic Complications Using ADME and Molecular Docking Studies and DFT Calculations of Spiroindoline Derivative Molecule. J. Nat. Appl. Sci. 2024;28(2):281-292. doi:10.19113/sdufenbed.1474689
Chicago
Gören, Kenan, and Ümit Yıldıko. 2024. “Aldose Reductase Evaluation Against Diabetic Complications Using ADME and Molecular Docking Studies and DFT Calculations of Spiroindoline Derivative Molecule”. Süleyman Demirel Üniversitesi Fen Bilimleri Enstitüsü Dergisi 28 (2): 281-92. https://doi.org/10.19113/sdufenbed.1474689.
EndNote
Gören K, Yıldıko Ü (August 1, 2024) Aldose Reductase Evaluation against Diabetic Complications Using ADME and Molecular Docking Studies and DFT Calculations of Spiroindoline Derivative Molecule. Süleyman Demirel Üniversitesi Fen Bilimleri Enstitüsü Dergisi 28 2 281–292.
IEEE
[1]K. Gören and Ü. Yıldıko, “Aldose Reductase Evaluation against Diabetic Complications Using ADME and Molecular Docking Studies and DFT Calculations of Spiroindoline Derivative Molecule”, J. Nat. Appl. Sci., vol. 28, no. 2, pp. 281–292, Aug. 2024, doi: 10.19113/sdufenbed.1474689.
ISNAD
Gören, Kenan - Yıldıko, Ümit. “Aldose Reductase Evaluation Against Diabetic Complications Using ADME and Molecular Docking Studies and DFT Calculations of Spiroindoline Derivative Molecule”. Süleyman Demirel Üniversitesi Fen Bilimleri Enstitüsü Dergisi 28/2 (August 1, 2024): 281-292. https://doi.org/10.19113/sdufenbed.1474689.
JAMA
1.Gören K, Yıldıko Ü. Aldose Reductase Evaluation against Diabetic Complications Using ADME and Molecular Docking Studies and DFT Calculations of Spiroindoline Derivative Molecule. J. Nat. Appl. Sci. 2024;28:281–292.
MLA
Gören, Kenan, and Ümit Yıldıko. “Aldose Reductase Evaluation Against Diabetic Complications Using ADME and Molecular Docking Studies and DFT Calculations of Spiroindoline Derivative Molecule”. Süleyman Demirel Üniversitesi Fen Bilimleri Enstitüsü Dergisi, vol. 28, no. 2, Aug. 2024, pp. 281-92, doi:10.19113/sdufenbed.1474689.
Vancouver
1.Kenan Gören, Ümit Yıldıko. Aldose Reductase Evaluation against Diabetic Complications Using ADME and Molecular Docking Studies and DFT Calculations of Spiroindoline Derivative Molecule. J. Nat. Appl. Sci. 2024 Aug. 1;28(2):281-92. doi:10.19113/sdufenbed.1474689

Cited By

e-ISSN :1308-6529
Linking ISSN (ISSN-L): 1300-7688

All published articles in the journal can be accessed free of charge and are open access under the Creative Commons CC BY-NC (Attribution-NonCommercial) license. All authors and other journal users are deemed to have accepted this situation. Click here to access detailed information about the CC BY-NC license.